Novo Nordisk (NVO) shares were down about 5% in recent trading on Thursday after HSBC downgraded the stock to hold from buy and cut its price target to $57 from $102.
Trading volume stood at more than 39.5 million shares against a daily average of about 12 million.
Price: 47.53, Change: -2.50, Percent Change: -5.00